Cargando…

Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes

AIM: To assess for passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts (TIPS) and compare outcomes with maximally dilated TIPS. METHODS: Polytetrafluoroethylene covered TIPS (Viatorr) from July 2002 to December 2013 were retrospectively reviewed at two hospitals...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Michael C, Weber, Charles N, Stavropoulos, S William, Clark, Timothy W, Trerotola, Scott O, Shlansky-Goldberg, Richard D, Soulen, Michael C, Nadolski, Gregory J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411955/
https://www.ncbi.nlm.nih.gov/pubmed/28515846
http://dx.doi.org/10.4254/wjh.v9.i12.603
_version_ 1783232888104288256
author Hsu, Michael C
Weber, Charles N
Stavropoulos, S William
Clark, Timothy W
Trerotola, Scott O
Shlansky-Goldberg, Richard D
Soulen, Michael C
Nadolski, Gregory J
author_facet Hsu, Michael C
Weber, Charles N
Stavropoulos, S William
Clark, Timothy W
Trerotola, Scott O
Shlansky-Goldberg, Richard D
Soulen, Michael C
Nadolski, Gregory J
author_sort Hsu, Michael C
collection PubMed
description AIM: To assess for passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts (TIPS) and compare outcomes with maximally dilated TIPS. METHODS: Polytetrafluoroethylene covered TIPS (Viatorr) from July 2002 to December 2013 were retrospectively reviewed at two hospitals in a single institution. Two hundred and thirty patients had TIPS maximally dilated to 10 mm (mTIPS), while 43 patients who were at increased risk for hepatic encephalopathy (HE), based on clinical evaluation or low pre-TIPS portosystemic gradient (PSG), had 10 mm TIPS sub-maximally dilated to 8 mm (smTIPS). Group characteristics (age, gender, Model for End-Stage Liver Disease score, post-TIPS PSG and clinical outcomes were compared between groups, including clinical success (ascites or varices), primary patency, primary assisted patency, and severe post-TIPS HE. A subset of fourteen patients with smTIPS underwent follow-up computed tomography imaging after TIPS creation, and were grouped based on time of imaging (< 6 mo and > 6 mo). Change in diameter and cross-sectional area were measured with 3D imaging software to evaluate for passive expansion. RESULTS: Patient characteristics were similar between the smTIPS and mTIPS groups, except for pre-TIPS portosystemic gradient, which was lower in the smTIPS group (19.4 mmHg ± 6.8 vs 22.4 mmHg ± 7.1, P = 0.01). Primary patency and primary assisted patency between smTIPS and mTIPS was not significantly different (P = 0.64 and 0.55, respectively). Four of the 55 patients (7%) with smTIPS required TIPS reduction for severe refractory HE, while this occurred in 6 of the 218 patients (3%) with mTIPS (P = 0.12). For the 14 patients with follow-up computed tomography (CT) imaging, the median imaging follow-up was 373 d. There was an increase in median TIPS diameter, median percent diameter change, median area, and median percent area change in patients with CT follow-up greater than 6 mo after TIPS placement compared to follow-up within 6 mo (8.45 mm, 5.58%, 56.04 mm(2), and 11.48%, respectively, P = 0.01). CONCLUSION: Passive expansion of smTIPS does occur but clinical outcomes of smTIPS and mTIPS were similar. Sub-maximal dilation can prevent complications related to over-shunting in select patients.
format Online
Article
Text
id pubmed-5411955
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-54119552017-05-17 Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes Hsu, Michael C Weber, Charles N Stavropoulos, S William Clark, Timothy W Trerotola, Scott O Shlansky-Goldberg, Richard D Soulen, Michael C Nadolski, Gregory J World J Hepatol Retrospective Study AIM: To assess for passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts (TIPS) and compare outcomes with maximally dilated TIPS. METHODS: Polytetrafluoroethylene covered TIPS (Viatorr) from July 2002 to December 2013 were retrospectively reviewed at two hospitals in a single institution. Two hundred and thirty patients had TIPS maximally dilated to 10 mm (mTIPS), while 43 patients who were at increased risk for hepatic encephalopathy (HE), based on clinical evaluation or low pre-TIPS portosystemic gradient (PSG), had 10 mm TIPS sub-maximally dilated to 8 mm (smTIPS). Group characteristics (age, gender, Model for End-Stage Liver Disease score, post-TIPS PSG and clinical outcomes were compared between groups, including clinical success (ascites or varices), primary patency, primary assisted patency, and severe post-TIPS HE. A subset of fourteen patients with smTIPS underwent follow-up computed tomography imaging after TIPS creation, and were grouped based on time of imaging (< 6 mo and > 6 mo). Change in diameter and cross-sectional area were measured with 3D imaging software to evaluate for passive expansion. RESULTS: Patient characteristics were similar between the smTIPS and mTIPS groups, except for pre-TIPS portosystemic gradient, which was lower in the smTIPS group (19.4 mmHg ± 6.8 vs 22.4 mmHg ± 7.1, P = 0.01). Primary patency and primary assisted patency between smTIPS and mTIPS was not significantly different (P = 0.64 and 0.55, respectively). Four of the 55 patients (7%) with smTIPS required TIPS reduction for severe refractory HE, while this occurred in 6 of the 218 patients (3%) with mTIPS (P = 0.12). For the 14 patients with follow-up computed tomography (CT) imaging, the median imaging follow-up was 373 d. There was an increase in median TIPS diameter, median percent diameter change, median area, and median percent area change in patients with CT follow-up greater than 6 mo after TIPS placement compared to follow-up within 6 mo (8.45 mm, 5.58%, 56.04 mm(2), and 11.48%, respectively, P = 0.01). CONCLUSION: Passive expansion of smTIPS does occur but clinical outcomes of smTIPS and mTIPS were similar. Sub-maximal dilation can prevent complications related to over-shunting in select patients. Baishideng Publishing Group Inc 2017-04-28 2017-04-28 /pmc/articles/PMC5411955/ /pubmed/28515846 http://dx.doi.org/10.4254/wjh.v9.i12.603 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Retrospective Study
Hsu, Michael C
Weber, Charles N
Stavropoulos, S William
Clark, Timothy W
Trerotola, Scott O
Shlansky-Goldberg, Richard D
Soulen, Michael C
Nadolski, Gregory J
Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes
title Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes
title_full Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes
title_fullStr Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes
title_full_unstemmed Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes
title_short Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes
title_sort passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411955/
https://www.ncbi.nlm.nih.gov/pubmed/28515846
http://dx.doi.org/10.4254/wjh.v9.i12.603
work_keys_str_mv AT hsumichaelc passiveexpansionofsubmaximallydilatedtransjugularintrahepaticportosystemicshuntsandassessmentofclinicaloutcomes
AT webercharlesn passiveexpansionofsubmaximallydilatedtransjugularintrahepaticportosystemicshuntsandassessmentofclinicaloutcomes
AT stavropoulosswilliam passiveexpansionofsubmaximallydilatedtransjugularintrahepaticportosystemicshuntsandassessmentofclinicaloutcomes
AT clarktimothyw passiveexpansionofsubmaximallydilatedtransjugularintrahepaticportosystemicshuntsandassessmentofclinicaloutcomes
AT trerotolascotto passiveexpansionofsubmaximallydilatedtransjugularintrahepaticportosystemicshuntsandassessmentofclinicaloutcomes
AT shlanskygoldbergrichardd passiveexpansionofsubmaximallydilatedtransjugularintrahepaticportosystemicshuntsandassessmentofclinicaloutcomes
AT soulenmichaelc passiveexpansionofsubmaximallydilatedtransjugularintrahepaticportosystemicshuntsandassessmentofclinicaloutcomes
AT nadolskigregoryj passiveexpansionofsubmaximallydilatedtransjugularintrahepaticportosystemicshuntsandassessmentofclinicaloutcomes